SANTA MONICA, Calif., May 26, 2016 /PRNewswire/ -- Today Doctor Evidence launches GROWTH Replicator, a site that provides stakeholders across the healthcare ecosystem free access to a platform for the replication of systematic evidence reviews. Doctor Evidence (DRE) is a leading human-enabled technology and services company that provides solutions for dynamic identification, synthesis, and analysis of clinical information to perform evidence-based medicine evaluations. DRE's GROWTH Replicator enables users to utilize Doctor Evidence's proprietary Digital Outcome Conversion (DOC) technology to reproduce reviews, and provides an open access interface for the stated data and methods of a review.
Through GROWTH Replicator, Doctor Evidence is providing an ecosystem where scientists and methodologists can communicate in an open forum by testing, iterating, investigating, and replicating an evidence review. "The GROWTH Replicator program is committed to providing the best available resources for collaborative science in any evidentiary review," stated Todd Feinman, MD, CMO and Co-founder of Doctor Evidence. "The transparency and reproducibility of healthcare analytics is essential if we are to rise above potentially unreliable black-box conclusions about which therapeutics should or shouldn't be accessible to patients—especially in today's age of determining value-based care."
The first review tested by GROWTH Replicator was a recently released report by the Institute for Clinical and Economic Review (ICER) addressing Multiple Myeloma. Users who enroll will have free access to their own protected login site, where they can view the underlying data used in this particular review. Investigators are encouraged to share their observations in the public forum of the GROWTH Replicator site to create a collaborative community for scientific debate. Users will also be able to use Doctor Evidence's integrated platform to view curated data, as well as utilize generally accepted open access R statistical models embedded in the platform to replicate the analysis, providing full transparency of methodology, data extractions, and conclusions.
The goal of GROWTH Replicator is to enable robust analysis of relevant clinical data in determining the efficacy and safety of healthcare interventions, to provide transparency by a standardized peer-replication system, and to create an open forum for scientists and methodologists. For more information or to request free access to GROWTH Replicator, visit http://growthevidence.com/replicator/.
About Doctor Evidence
Doctor Evidence, LLC, founded in 2004, is a leader in technological solutions for evidence-based medicine reviews and analysis. The company provides stakeholders across the healthcare ecosystem with timely and relevant medical evidence and related analytics to make and inform the best clinical decisions. Doctor Evidence is best known for its proprietary Digital Outcome Conversion (DOC) platform; its rigorous methodology of extracting clinical data from static, unstructured sources, including published studies, epidemiological databases, drug label; and for creating dynamic, scientifically-curated data hubs. The digitized data can be pooled and analyzed to support the development of evidence-based clinical practice guideline recommendations, systematic reviews, and health technology assessments, as well as regulatory and policy submissions. The company's goal is to support efforts of healthcare providers, healthcare professionals and patients to gain access to important evidence-based knowledge and to improve the health and wellbeing of patients worldwide. Doctor Evidence is a global company headquartered in Santa Monica, California. For more information on Doctor Evidence innovations, please visit http://www.drevidence.com and http://growthevidence.com/replicator/
SOURCE Doctor Evidence